nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—systemic scleroderma—systemic lupus erythematosus	0.849	1	CtDrD
Pentoxifylline—PDE5A—endothelium—systemic lupus erythematosus	0.0026	0.0606	CbGeAlD
Pentoxifylline—PDE5A—blood plasma—systemic lupus erythematosus	0.00231	0.0538	CbGeAlD
Pentoxifylline—CYP1A2—urine—systemic lupus erythematosus	0.00191	0.0444	CbGeAlD
Pentoxifylline—NT5E—connective tissue—systemic lupus erythematosus	0.0019	0.0442	CbGeAlD
Pentoxifylline—NT5E—nephron tubule—systemic lupus erythematosus	0.00184	0.0428	CbGeAlD
Pentoxifylline—NT5E—skin of body—systemic lupus erythematosus	0.00171	0.0399	CbGeAlD
Pentoxifylline—NT5E—kidney—systemic lupus erythematosus	0.00162	0.0376	CbGeAlD
Pentoxifylline—NT5E—cortex of kidney—systemic lupus erythematosus	0.00157	0.0366	CbGeAlD
Pentoxifylline—NT5E—lymphoid tissue—systemic lupus erythematosus	0.00139	0.0323	CbGeAlD
Pentoxifylline—NT5E—tendon—systemic lupus erythematosus	0.0013	0.0304	CbGeAlD
Pentoxifylline—NT5E—bone marrow—systemic lupus erythematosus	0.00126	0.0294	CbGeAlD
Pentoxifylline—PDE5A—connective tissue—systemic lupus erythematosus	0.00123	0.0287	CbGeAlD
Pentoxifylline—NT5E—lung—systemic lupus erythematosus	0.00114	0.0266	CbGeAlD
Pentoxifylline—NT5E—nervous system—systemic lupus erythematosus	0.00106	0.0247	CbGeAlD
Pentoxifylline—NT5E—central nervous system—systemic lupus erythematosus	0.00102	0.0237	CbGeAlD
Pentoxifylline—CYP1A2—blood plasma—systemic lupus erythematosus	0.000996	0.0232	CbGeAlD
Pentoxifylline—ADORA1—kidney—systemic lupus erythematosus	0.000994	0.0231	CbGeAlD
Pentoxifylline—ADORA2A—lymphoid tissue—systemic lupus erythematosus	0.000989	0.023	CbGeAlD
Pentoxifylline—ADORA2B—lung—systemic lupus erythematosus	0.00098	0.0228	CbGeAlD
Pentoxifylline—ADORA1—cortex of kidney—systemic lupus erythematosus	0.000968	0.0225	CbGeAlD
Pentoxifylline—ADORA2B—nervous system—systemic lupus erythematosus	0.000908	0.0211	CbGeAlD
Pentoxifylline—ADORA2B—central nervous system—systemic lupus erythematosus	0.000874	0.0203	CbGeAlD
Pentoxifylline—PDE4A—lung—systemic lupus erythematosus	0.000874	0.0203	CbGeAlD
Pentoxifylline—PDE5A—tendon—systemic lupus erythematosus	0.000847	0.0197	CbGeAlD
Pentoxifylline—ADORA1—tendon—systemic lupus erythematosus	0.000803	0.0187	CbGeAlD
Pentoxifylline—ADORA2A—nervous system—systemic lupus erythematosus	0.000755	0.0176	CbGeAlD
Pentoxifylline—PDE5A—lung—systemic lupus erythematosus	0.000743	0.0173	CbGeAlD
Pentoxifylline—ADORA2A—central nervous system—systemic lupus erythematosus	0.000727	0.0169	CbGeAlD
Pentoxifylline—PDE4B—cortex of kidney—systemic lupus erythematosus	0.000716	0.0167	CbGeAlD
Pentoxifylline—ADORA1—lung—systemic lupus erythematosus	0.000704	0.0164	CbGeAlD
Pentoxifylline—PDE5A—nervous system—systemic lupus erythematosus	0.000688	0.016	CbGeAlD
Pentoxifylline—PDE5A—central nervous system—systemic lupus erythematosus	0.000662	0.0154	CbGeAlD
Pentoxifylline—ADORA1—nervous system—systemic lupus erythematosus	0.000652	0.0152	CbGeAlD
Pentoxifylline—PDE4B—lymphoid tissue—systemic lupus erythematosus	0.000631	0.0147	CbGeAlD
Pentoxifylline—ADORA1—central nervous system—systemic lupus erythematosus	0.000628	0.0146	CbGeAlD
Pentoxifylline—PDE4B—tendon—systemic lupus erythematosus	0.000594	0.0138	CbGeAlD
Pentoxifylline—PDE4B—bone marrow—systemic lupus erythematosus	0.000575	0.0134	CbGeAlD
Pentoxifylline—PDE4B—lung—systemic lupus erythematosus	0.000521	0.0121	CbGeAlD
Pentoxifylline—PDE4B—nervous system—systemic lupus erythematosus	0.000482	0.0112	CbGeAlD
Pentoxifylline—PDE4B—central nervous system—systemic lupus erythematosus	0.000464	0.0108	CbGeAlD
Pentoxifylline—CYP1A2—lung—systemic lupus erythematosus	0.00032	0.00745	CbGeAlD
Pentoxifylline—Rash—Leflunomide—systemic lupus erythematosus	0.00011	0.00122	CcSEcCtD
Pentoxifylline—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.00011	0.00122	CcSEcCtD
Pentoxifylline—Dermatitis—Leflunomide—systemic lupus erythematosus	0.00011	0.00122	CcSEcCtD
Pentoxifylline—Nausea—Azathioprine—systemic lupus erythematosus	0.00011	0.00122	CcSEcCtD
Pentoxifylline—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.00011	0.00122	CcSEcCtD
Pentoxifylline—Headache—Leflunomide—systemic lupus erythematosus	0.000109	0.00122	CcSEcCtD
Pentoxifylline—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000109	0.00122	CcSEcCtD
Pentoxifylline—Erythema—Prednisone—systemic lupus erythematosus	0.000109	0.00121	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000109	0.00121	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000109	0.00121	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000109	0.00121	CcSEcCtD
Pentoxifylline—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000108	0.00121	CcSEcCtD
Pentoxifylline—Convulsion—Betamethasone—systemic lupus erythematosus	0.000108	0.00121	CcSEcCtD
Pentoxifylline—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000108	0.00121	CcSEcCtD
Pentoxifylline—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000108	0.00121	CcSEcCtD
Pentoxifylline—Hypertension—Betamethasone—systemic lupus erythematosus	0.000108	0.0012	CcSEcCtD
Pentoxifylline—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000108	0.0012	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000107	0.0012	CcSEcCtD
Pentoxifylline—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000107	0.00119	CcSEcCtD
Pentoxifylline—Myalgia—Betamethasone—systemic lupus erythematosus	0.000106	0.00119	CcSEcCtD
Pentoxifylline—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000106	0.00119	CcSEcCtD
Pentoxifylline—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000106	0.00119	CcSEcCtD
Pentoxifylline—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000106	0.00119	CcSEcCtD
Pentoxifylline—Anxiety—Betamethasone—systemic lupus erythematosus	0.000106	0.00118	CcSEcCtD
Pentoxifylline—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000106	0.00118	CcSEcCtD
Pentoxifylline—Discomfort—Betamethasone—systemic lupus erythematosus	0.000105	0.00117	CcSEcCtD
Pentoxifylline—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000105	0.00117	CcSEcCtD
Pentoxifylline—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000105	0.00117	CcSEcCtD
Pentoxifylline—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000105	0.00117	CcSEcCtD
Pentoxifylline—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000105	0.00117	CcSEcCtD
Pentoxifylline—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000105	0.00117	CcSEcCtD
Pentoxifylline—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000105	0.00117	CcSEcCtD
Pentoxifylline—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000104	0.00116	CcSEcCtD
Pentoxifylline—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000104	0.00116	CcSEcCtD
Pentoxifylline—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000104	0.00116	CcSEcCtD
Pentoxifylline—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000104	0.00116	CcSEcCtD
Pentoxifylline—Nausea—Leflunomide—systemic lupus erythematosus	0.000103	0.00115	CcSEcCtD
Pentoxifylline—Vision blurred—Prednisone—systemic lupus erythematosus	0.000103	0.00114	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000102	0.00114	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000102	0.00114	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000102	0.00114	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000102	0.00114	CcSEcCtD
Pentoxifylline—Oedema—Dexamethasone—systemic lupus erythematosus	0.000102	0.00114	CcSEcCtD
Pentoxifylline—Oedema—Betamethasone—systemic lupus erythematosus	0.000102	0.00114	CcSEcCtD
Pentoxifylline—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000102	0.00113	CcSEcCtD
Pentoxifylline—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000102	0.00113	CcSEcCtD
Pentoxifylline—Infection—Dexamethasone—systemic lupus erythematosus	0.000101	0.00113	CcSEcCtD
Pentoxifylline—Infection—Betamethasone—systemic lupus erythematosus	0.000101	0.00113	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000101	0.00113	CcSEcCtD
Pentoxifylline—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000101	0.00112	CcSEcCtD
Pentoxifylline—Anaemia—Prednisone—systemic lupus erythematosus	0.000101	0.00112	CcSEcCtD
Pentoxifylline—Shock—Betamethasone—systemic lupus erythematosus	0.0001	0.00112	CcSEcCtD
Pentoxifylline—Shock—Dexamethasone—systemic lupus erythematosus	0.0001	0.00112	CcSEcCtD
Pentoxifylline—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.0001	0.00112	CcSEcCtD
Pentoxifylline—Agitation—Prednisone—systemic lupus erythematosus	0.0001	0.00112	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	9.99e-05	0.00111	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	9.99e-05	0.00111	CcSEcCtD
Pentoxifylline—Tachycardia—Dexamethasone—systemic lupus erythematosus	9.96e-05	0.00111	CcSEcCtD
Pentoxifylline—Tachycardia—Betamethasone—systemic lupus erythematosus	9.96e-05	0.00111	CcSEcCtD
Pentoxifylline—Angioedema—Prednisone—systemic lupus erythematosus	9.95e-05	0.00111	CcSEcCtD
Pentoxifylline—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	9.9e-05	0.0011	CcSEcCtD
Pentoxifylline—Dyspepsia—Triamcinolone—systemic lupus erythematosus	9.9e-05	0.0011	CcSEcCtD
Pentoxifylline—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	9.88e-05	0.0011	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	9.87e-05	0.0011	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	9.87e-05	0.0011	CcSEcCtD
Pentoxifylline—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	9.84e-05	0.0011	CcSEcCtD
Pentoxifylline—Malaise—Prednisone—systemic lupus erythematosus	9.82e-05	0.0011	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	9.77e-05	0.00109	CcSEcCtD
Pentoxifylline—Anorexia—Dexamethasone—systemic lupus erythematosus	9.73e-05	0.00109	CcSEcCtD
Pentoxifylline—Anorexia—Betamethasone—systemic lupus erythematosus	9.73e-05	0.00109	CcSEcCtD
Pentoxifylline—Urticaria—Prednisolone—systemic lupus erythematosus	9.72e-05	0.00108	CcSEcCtD
Pentoxifylline—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	9.66e-05	0.00108	CcSEcCtD
Pentoxifylline—Asthenia—Cyclosporine—systemic lupus erythematosus	9.64e-05	0.00108	CcSEcCtD
Pentoxifylline—Hypotension—Betamethasone—systemic lupus erythematosus	9.54e-05	0.00106	CcSEcCtD
Pentoxifylline—Hypotension—Dexamethasone—systemic lupus erythematosus	9.54e-05	0.00106	CcSEcCtD
Pentoxifylline—Pruritus—Cyclosporine—systemic lupus erythematosus	9.51e-05	0.00106	CcSEcCtD
Pentoxifylline—Urticaria—Hydrocortisone—systemic lupus erythematosus	9.49e-05	0.00106	CcSEcCtD
Pentoxifylline—Immune system disorder—Methotrexate—systemic lupus erythematosus	9.44e-05	0.00105	CcSEcCtD
Pentoxifylline—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	9.44e-05	0.00105	CcSEcCtD
Pentoxifylline—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	9.44e-05	0.00105	CcSEcCtD
Pentoxifylline—Convulsion—Prednisone—systemic lupus erythematosus	9.44e-05	0.00105	CcSEcCtD
Pentoxifylline—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	9.41e-05	0.00105	CcSEcCtD
Pentoxifylline—Hypertension—Prednisone—systemic lupus erythematosus	9.4e-05	0.00105	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	9.3e-05	0.00104	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	9.3e-05	0.00104	CcSEcCtD
Pentoxifylline—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	9.28e-05	0.00103	CcSEcCtD
Pentoxifylline—Myalgia—Prednisone—systemic lupus erythematosus	9.27e-05	0.00103	CcSEcCtD
Pentoxifylline—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	9.27e-05	0.00103	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	9.25e-05	0.00103	CcSEcCtD
Pentoxifylline—Anxiety—Prednisone—systemic lupus erythematosus	9.24e-05	0.00103	CcSEcCtD
Pentoxifylline—Insomnia—Betamethasone—systemic lupus erythematosus	9.23e-05	0.00103	CcSEcCtD
Pentoxifylline—Insomnia—Dexamethasone—systemic lupus erythematosus	9.23e-05	0.00103	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	9.21e-05	0.00103	CcSEcCtD
Pentoxifylline—Diarrhoea—Cyclosporine—systemic lupus erythematosus	9.2e-05	0.00103	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	9.18e-05	0.00102	CcSEcCtD
Pentoxifylline—Discomfort—Prednisone—systemic lupus erythematosus	9.16e-05	0.00102	CcSEcCtD
Pentoxifylline—Erythema—Methotrexate—systemic lupus erythematosus	9.1e-05	0.00102	CcSEcCtD
Pentoxifylline—Hypersensitivity—Prednisolone—systemic lupus erythematosus	9.01e-05	0.00101	CcSEcCtD
Pentoxifylline—Dyspepsia—Dexamethasone—systemic lupus erythematosus	8.98e-05	0.001	CcSEcCtD
Pentoxifylline—Dyspepsia—Betamethasone—systemic lupus erythematosus	8.98e-05	0.001	CcSEcCtD
Pentoxifylline—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	8.97e-05	0.001	CcSEcCtD
Pentoxifylline—Urticaria—Triamcinolone—systemic lupus erythematosus	8.94e-05	0.000997	CcSEcCtD
Pentoxifylline—Urticaria—Methylprednisolone—systemic lupus erythematosus	8.92e-05	0.000995	CcSEcCtD
Pentoxifylline—Dysgeusia—Methotrexate—systemic lupus erythematosus	8.91e-05	0.000994	CcSEcCtD
Pentoxifylline—Body temperature increased—Triamcinolone—systemic lupus erythematosus	8.89e-05	0.000992	CcSEcCtD
Pentoxifylline—Dizziness—Cyclosporine—systemic lupus erythematosus	8.89e-05	0.000991	CcSEcCtD
Pentoxifylline—Oedema—Prednisone—systemic lupus erythematosus	8.89e-05	0.000991	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Prednisone—systemic lupus erythematosus	8.89e-05	0.000991	CcSEcCtD
Pentoxifylline—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	8.87e-05	0.00099	CcSEcCtD
Pentoxifylline—Decreased appetite—Betamethasone—systemic lupus erythematosus	8.87e-05	0.00099	CcSEcCtD
Pentoxifylline—Decreased appetite—Dexamethasone—systemic lupus erythematosus	8.87e-05	0.00099	CcSEcCtD
Pentoxifylline—Infection—Prednisone—systemic lupus erythematosus	8.83e-05	0.000985	CcSEcCtD
Pentoxifylline—Back pain—Methotrexate—systemic lupus erythematosus	8.8e-05	0.000982	CcSEcCtD
Pentoxifylline—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	8.8e-05	0.000982	CcSEcCtD
Pentoxifylline—Shock—Prednisone—systemic lupus erythematosus	8.75e-05	0.000975	CcSEcCtD
Pentoxifylline—Tachycardia—Prednisone—systemic lupus erythematosus	8.68e-05	0.000968	CcSEcCtD
Pentoxifylline—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	8.67e-05	0.000967	CcSEcCtD
Pentoxifylline—Skin disorder—Prednisone—systemic lupus erythematosus	8.63e-05	0.000963	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisone—systemic lupus erythematosus	8.59e-05	0.000958	CcSEcCtD
Pentoxifylline—Vision blurred—Methotrexate—systemic lupus erythematosus	8.58e-05	0.000957	CcSEcCtD
Pentoxifylline—Asthenia—Hydrocortisone—systemic lupus erythematosus	8.57e-05	0.000956	CcSEcCtD
Pentoxifylline—Vomiting—Cyclosporine—systemic lupus erythematosus	8.55e-05	0.000953	CcSEcCtD
Pentoxifylline—Rash—Cyclosporine—systemic lupus erythematosus	8.48e-05	0.000945	CcSEcCtD
Pentoxifylline—Anorexia—Prednisone—systemic lupus erythematosus	8.47e-05	0.000945	CcSEcCtD
Pentoxifylline—Dermatitis—Cyclosporine—systemic lupus erythematosus	8.47e-05	0.000944	CcSEcCtD
Pentoxifylline—Pruritus—Hydrocortisone—systemic lupus erythematosus	8.45e-05	0.000943	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	8.45e-05	0.000942	CcSEcCtD
Pentoxifylline—Headache—Cyclosporine—systemic lupus erythematosus	8.42e-05	0.000939	CcSEcCtD
Pentoxifylline—Anaemia—Methotrexate—systemic lupus erythematosus	8.41e-05	0.000938	CcSEcCtD
Pentoxifylline—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	8.41e-05	0.000938	CcSEcCtD
Pentoxifylline—Feeling abnormal—Betamethasone—systemic lupus erythematosus	8.41e-05	0.000938	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	8.35e-05	0.000931	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	8.35e-05	0.000931	CcSEcCtD
Pentoxifylline—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	8.34e-05	0.00093	CcSEcCtD
Pentoxifylline—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	8.29e-05	0.000924	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	8.27e-05	0.000922	CcSEcCtD
Pentoxifylline—Rash—Mycophenolate mofetil—systemic lupus erythematosus	8.27e-05	0.000922	CcSEcCtD
Pentoxifylline—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	8.26e-05	0.000921	CcSEcCtD
Pentoxifylline—Headache—Mycophenolate mofetil—systemic lupus erythematosus	8.21e-05	0.000916	CcSEcCtD
Pentoxifylline—Malaise—Methotrexate—systemic lupus erythematosus	8.21e-05	0.000916	CcSEcCtD
Pentoxifylline—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	8.17e-05	0.000912	CcSEcCtD
Pentoxifylline—Leukopenia—Methotrexate—systemic lupus erythematosus	8.15e-05	0.000909	CcSEcCtD
Pentoxifylline—Urticaria—Betamethasone—systemic lupus erythematosus	8.11e-05	0.000904	CcSEcCtD
Pentoxifylline—Urticaria—Dexamethasone—systemic lupus erythematosus	8.11e-05	0.000904	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	8.1e-05	0.000903	CcSEcCtD
Pentoxifylline—Dizziness—Prednisolone—systemic lupus erythematosus	8.09e-05	0.000902	CcSEcCtD
Pentoxifylline—Asthenia—Triamcinolone—systemic lupus erythematosus	8.07e-05	0.0009	CcSEcCtD
Pentoxifylline—Body temperature increased—Dexamethasone—systemic lupus erythematosus	8.07e-05	0.0009	CcSEcCtD
Pentoxifylline—Body temperature increased—Betamethasone—systemic lupus erythematosus	8.07e-05	0.0009	CcSEcCtD
Pentoxifylline—Abdominal pain—Betamethasone—systemic lupus erythematosus	8.07e-05	0.0009	CcSEcCtD
Pentoxifylline—Abdominal pain—Dexamethasone—systemic lupus erythematosus	8.07e-05	0.0009	CcSEcCtD
Pentoxifylline—Asthenia—Methylprednisolone—systemic lupus erythematosus	8.05e-05	0.000898	CcSEcCtD
Pentoxifylline—Insomnia—Prednisone—systemic lupus erythematosus	8.04e-05	0.000897	CcSEcCtD
Pentoxifylline—Nausea—Cyclosporine—systemic lupus erythematosus	7.98e-05	0.000891	CcSEcCtD
Pentoxifylline—Pruritus—Triamcinolone—systemic lupus erythematosus	7.96e-05	0.000888	CcSEcCtD
Pentoxifylline—Pruritus—Methylprednisolone—systemic lupus erythematosus	7.94e-05	0.000886	CcSEcCtD
Pentoxifylline—Dizziness—Hydrocortisone—systemic lupus erythematosus	7.9e-05	0.000881	CcSEcCtD
Pentoxifylline—Convulsion—Methotrexate—systemic lupus erythematosus	7.89e-05	0.00088	CcSEcCtD
Pentoxifylline—Dyspepsia—Prednisone—systemic lupus erythematosus	7.82e-05	0.000873	CcSEcCtD
Pentoxifylline—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	7.79e-05	0.000869	CcSEcCtD
Pentoxifylline—Chest pain—Methotrexate—systemic lupus erythematosus	7.75e-05	0.000864	CcSEcCtD
Pentoxifylline—Myalgia—Methotrexate—systemic lupus erythematosus	7.75e-05	0.000864	CcSEcCtD
Pentoxifylline—Decreased appetite—Prednisone—systemic lupus erythematosus	7.73e-05	0.000862	CcSEcCtD
Pentoxifylline—Rash—Prednisolone—systemic lupus erythematosus	7.71e-05	0.00086	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisolone—systemic lupus erythematosus	7.71e-05	0.000859	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	7.7e-05	0.000858	CcSEcCtD
Pentoxifylline—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	7.68e-05	0.000857	CcSEcCtD
Pentoxifylline—Headache—Prednisolone—systemic lupus erythematosus	7.66e-05	0.000855	CcSEcCtD
Pentoxifylline—Discomfort—Methotrexate—systemic lupus erythematosus	7.66e-05	0.000854	CcSEcCtD
Pentoxifylline—Constipation—Prednisone—systemic lupus erythematosus	7.6e-05	0.000848	CcSEcCtD
Pentoxifylline—Vomiting—Hydrocortisone—systemic lupus erythematosus	7.6e-05	0.000847	CcSEcCtD
Pentoxifylline—Rash—Hydrocortisone—systemic lupus erythematosus	7.53e-05	0.00084	CcSEcCtD
Pentoxifylline—Dermatitis—Hydrocortisone—systemic lupus erythematosus	7.53e-05	0.000839	CcSEcCtD
Pentoxifylline—Confusional state—Methotrexate—systemic lupus erythematosus	7.49e-05	0.000835	CcSEcCtD
Pentoxifylline—Headache—Hydrocortisone—systemic lupus erythematosus	7.48e-05	0.000835	CcSEcCtD
Pentoxifylline—Dizziness—Triamcinolone—systemic lupus erythematosus	7.44e-05	0.00083	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	7.43e-05	0.000829	CcSEcCtD
Pentoxifylline—Dizziness—Methylprednisolone—systemic lupus erythematosus	7.42e-05	0.000828	CcSEcCtD
Pentoxifylline—Infection—Methotrexate—systemic lupus erythematosus	7.38e-05	0.000823	CcSEcCtD
Pentoxifylline—Feeling abnormal—Prednisone—systemic lupus erythematosus	7.32e-05	0.000817	CcSEcCtD
Pentoxifylline—Asthenia—Betamethasone—systemic lupus erythematosus	7.32e-05	0.000817	CcSEcCtD
Pentoxifylline—Asthenia—Dexamethasone—systemic lupus erythematosus	7.32e-05	0.000817	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	7.27e-05	0.000811	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	7.27e-05	0.000811	CcSEcCtD
Pentoxifylline—Nausea—Prednisolone—systemic lupus erythematosus	7.27e-05	0.00081	CcSEcCtD
Pentoxifylline—Pruritus—Dexamethasone—systemic lupus erythematosus	7.22e-05	0.000805	CcSEcCtD
Pentoxifylline—Pruritus—Betamethasone—systemic lupus erythematosus	7.22e-05	0.000805	CcSEcCtD
Pentoxifylline—Skin disorder—Methotrexate—systemic lupus erythematosus	7.22e-05	0.000805	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	7.18e-05	0.000801	CcSEcCtD
Pentoxifylline—Vomiting—Triamcinolone—systemic lupus erythematosus	7.15e-05	0.000798	CcSEcCtD
Pentoxifylline—Vomiting—Methylprednisolone—systemic lupus erythematosus	7.14e-05	0.000796	CcSEcCtD
Pentoxifylline—Nausea—Hydrocortisone—systemic lupus erythematosus	7.1e-05	0.000791	CcSEcCtD
Pentoxifylline—Rash—Triamcinolone—systemic lupus erythematosus	7.09e-05	0.000791	CcSEcCtD
Pentoxifylline—Dermatitis—Triamcinolone—systemic lupus erythematosus	7.09e-05	0.00079	CcSEcCtD
Pentoxifylline—Anorexia—Methotrexate—systemic lupus erythematosus	7.08e-05	0.00079	CcSEcCtD
Pentoxifylline—Rash—Methylprednisolone—systemic lupus erythematosus	7.08e-05	0.000789	CcSEcCtD
Pentoxifylline—Dermatitis—Methylprednisolone—systemic lupus erythematosus	7.07e-05	0.000789	CcSEcCtD
Pentoxifylline—Urticaria—Prednisone—systemic lupus erythematosus	7.06e-05	0.000788	CcSEcCtD
Pentoxifylline—Headache—Triamcinolone—systemic lupus erythematosus	7.05e-05	0.000786	CcSEcCtD
Pentoxifylline—Headache—Methylprednisolone—systemic lupus erythematosus	7.03e-05	0.000784	CcSEcCtD
Pentoxifylline—Abdominal pain—Prednisone—systemic lupus erythematosus	7.03e-05	0.000784	CcSEcCtD
Pentoxifylline—Body temperature increased—Prednisone—systemic lupus erythematosus	7.03e-05	0.000784	CcSEcCtD
Pentoxifylline—Diarrhoea—Dexamethasone—systemic lupus erythematosus	6.98e-05	0.000779	CcSEcCtD
Pentoxifylline—Diarrhoea—Betamethasone—systemic lupus erythematosus	6.98e-05	0.000779	CcSEcCtD
Pentoxifylline—Hypotension—Methotrexate—systemic lupus erythematosus	6.94e-05	0.000774	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	6.77e-05	0.000755	CcSEcCtD
Pentoxifylline—Dizziness—Betamethasone—systemic lupus erythematosus	6.75e-05	0.000753	CcSEcCtD
Pentoxifylline—Dizziness—Dexamethasone—systemic lupus erythematosus	6.75e-05	0.000753	CcSEcCtD
Pentoxifylline—Insomnia—Methotrexate—systemic lupus erythematosus	6.72e-05	0.000749	CcSEcCtD
Pentoxifylline—Nausea—Triamcinolone—systemic lupus erythematosus	6.68e-05	0.000745	CcSEcCtD
Pentoxifylline—Nausea—Methylprednisolone—systemic lupus erythematosus	6.67e-05	0.000744	CcSEcCtD
Pentoxifylline—Dyspnoea—Methotrexate—systemic lupus erythematosus	6.62e-05	0.000739	CcSEcCtD
Pentoxifylline—Somnolence—Methotrexate—systemic lupus erythematosus	6.6e-05	0.000737	CcSEcCtD
Pentoxifylline—Hypersensitivity—Prednisone—systemic lupus erythematosus	6.55e-05	0.00073	CcSEcCtD
Pentoxifylline—Dyspepsia—Methotrexate—systemic lupus erythematosus	6.54e-05	0.000729	CcSEcCtD
Pentoxifylline—Vomiting—Dexamethasone—systemic lupus erythematosus	6.49e-05	0.000724	CcSEcCtD
Pentoxifylline—Vomiting—Betamethasone—systemic lupus erythematosus	6.49e-05	0.000724	CcSEcCtD
Pentoxifylline—Decreased appetite—Methotrexate—systemic lupus erythematosus	6.46e-05	0.00072	CcSEcCtD
Pentoxifylline—Rash—Dexamethasone—systemic lupus erythematosus	6.44e-05	0.000718	CcSEcCtD
Pentoxifylline—Rash—Betamethasone—systemic lupus erythematosus	6.44e-05	0.000718	CcSEcCtD
Pentoxifylline—Dermatitis—Betamethasone—systemic lupus erythematosus	6.43e-05	0.000717	CcSEcCtD
Pentoxifylline—Dermatitis—Dexamethasone—systemic lupus erythematosus	6.43e-05	0.000717	CcSEcCtD
Pentoxifylline—Headache—Dexamethasone—systemic lupus erythematosus	6.39e-05	0.000713	CcSEcCtD
Pentoxifylline—Headache—Betamethasone—systemic lupus erythematosus	6.39e-05	0.000713	CcSEcCtD
Pentoxifylline—Asthenia—Prednisone—systemic lupus erythematosus	6.38e-05	0.000711	CcSEcCtD
Pentoxifylline—Pruritus—Prednisone—systemic lupus erythematosus	6.29e-05	0.000701	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methotrexate—systemic lupus erythematosus	6.12e-05	0.000683	CcSEcCtD
Pentoxifylline—Diarrhoea—Prednisone—systemic lupus erythematosus	6.08e-05	0.000678	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	6.07e-05	0.000678	CcSEcCtD
Pentoxifylline—Nausea—Dexamethasone—systemic lupus erythematosus	6.06e-05	0.000676	CcSEcCtD
Pentoxifylline—Nausea—Betamethasone—systemic lupus erythematosus	6.06e-05	0.000676	CcSEcCtD
Pentoxifylline—Urticaria—Methotrexate—systemic lupus erythematosus	5.9e-05	0.000658	CcSEcCtD
Pentoxifylline—Dizziness—Prednisone—systemic lupus erythematosus	5.88e-05	0.000656	CcSEcCtD
Pentoxifylline—Abdominal pain—Methotrexate—systemic lupus erythematosus	5.87e-05	0.000655	CcSEcCtD
Pentoxifylline—Body temperature increased—Methotrexate—systemic lupus erythematosus	5.87e-05	0.000655	CcSEcCtD
Pentoxifylline—Vomiting—Prednisone—systemic lupus erythematosus	5.65e-05	0.00063	CcSEcCtD
Pentoxifylline—Rash—Prednisone—systemic lupus erythematosus	5.6e-05	0.000625	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisone—systemic lupus erythematosus	5.6e-05	0.000625	CcSEcCtD
Pentoxifylline—Headache—Prednisone—systemic lupus erythematosus	5.57e-05	0.000621	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methotrexate—systemic lupus erythematosus	5.47e-05	0.00061	CcSEcCtD
Pentoxifylline—Asthenia—Methotrexate—systemic lupus erythematosus	5.33e-05	0.000594	CcSEcCtD
Pentoxifylline—Nausea—Prednisone—systemic lupus erythematosus	5.28e-05	0.000589	CcSEcCtD
Pentoxifylline—Pruritus—Methotrexate—systemic lupus erythematosus	5.26e-05	0.000586	CcSEcCtD
Pentoxifylline—Diarrhoea—Methotrexate—systemic lupus erythematosus	5.08e-05	0.000567	CcSEcCtD
Pentoxifylline—Dizziness—Methotrexate—systemic lupus erythematosus	4.91e-05	0.000548	CcSEcCtD
Pentoxifylline—Vomiting—Methotrexate—systemic lupus erythematosus	4.72e-05	0.000527	CcSEcCtD
Pentoxifylline—Rash—Methotrexate—systemic lupus erythematosus	4.68e-05	0.000522	CcSEcCtD
Pentoxifylline—Dermatitis—Methotrexate—systemic lupus erythematosus	4.68e-05	0.000522	CcSEcCtD
Pentoxifylline—Headache—Methotrexate—systemic lupus erythematosus	4.65e-05	0.000519	CcSEcCtD
Pentoxifylline—Nausea—Methotrexate—systemic lupus erythematosus	4.41e-05	0.000492	CcSEcCtD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	2.49e-05	0.00133	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TGFB1—systemic lupus erythematosus	2.49e-05	0.00133	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.46e-05	0.00132	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—JAK1—systemic lupus erythematosus	2.46e-05	0.00132	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	2.45e-05	0.00131	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	2.42e-05	0.00129	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TLR9—systemic lupus erythematosus	2.38e-05	0.00127	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	2.37e-05	0.00127	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	2.37e-05	0.00127	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TLR9—systemic lupus erythematosus	2.35e-05	0.00126	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PPARG—systemic lupus erythematosus	2.34e-05	0.00125	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CCR5—systemic lupus erythematosus	2.33e-05	0.00125	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.33e-05	0.00124	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—F2—systemic lupus erythematosus	2.32e-05	0.00124	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.31e-05	0.00123	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	2.3e-05	0.00123	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NCF2—systemic lupus erythematosus	2.28e-05	0.00122	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.28e-05	0.00122	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—C3—systemic lupus erythematosus	2.28e-05	0.00122	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—LYN—systemic lupus erythematosus	2.27e-05	0.00121	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CSK—systemic lupus erythematosus	2.27e-05	0.00121	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—CDKN1B—systemic lupus erythematosus	2.26e-05	0.00121	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.25e-05	0.0012	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—JAK1—systemic lupus erythematosus	2.23e-05	0.00119	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	2.23e-05	0.00119	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	2.23e-05	0.00119	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—IL6—systemic lupus erythematosus	2.23e-05	0.00119	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.22e-05	0.00119	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.18e-05	0.00116	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.15e-05	0.00115	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CSK—systemic lupus erythematosus	2.12e-05	0.00113	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.12e-05	0.00113	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	2.12e-05	0.00113	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ALB—systemic lupus erythematosus	2.11e-05	0.00113	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CSK—systemic lupus erythematosus	2.1e-05	0.00112	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	2.09e-05	0.00112	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.09e-05	0.00112	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	2.09e-05	0.00112	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—CDKN1A—systemic lupus erythematosus	2.08e-05	0.00111	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	2.08e-05	0.00111	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NCF2—systemic lupus erythematosus	2.07e-05	0.00111	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CCL2—systemic lupus erythematosus	2.07e-05	0.00111	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—C3—systemic lupus erythematosus	2.07e-05	0.00111	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—C3—systemic lupus erythematosus	2.07e-05	0.00111	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—JAK1—systemic lupus erythematosus	2.07e-05	0.00111	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	2.06e-05	0.0011	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—LYN—systemic lupus erythematosus	2.06e-05	0.0011	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—JAK1—systemic lupus erythematosus	2.03e-05	0.00108	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	2.03e-05	0.00108	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.02e-05	0.00108	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—NOS3—systemic lupus erythematosus	2.02e-05	0.00108	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—F2—systemic lupus erythematosus	2e-05	0.00107	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	2e-05	0.00107	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.98e-05	0.00106	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.96e-05	0.00105	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.95e-05	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NCF2—systemic lupus erythematosus	1.94e-05	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—C3—systemic lupus erythematosus	1.94e-05	0.00104	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.93e-05	0.00103	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—LYN—systemic lupus erythematosus	1.93e-05	0.00103	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	1.93e-05	0.00103	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	1.93e-05	0.00103	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.92e-05	0.00103	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NCF2—systemic lupus erythematosus	1.92e-05	0.00103	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—C3—systemic lupus erythematosus	1.91e-05	0.00102	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—LYN—systemic lupus erythematosus	1.91e-05	0.00102	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.9e-05	0.00102	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.89e-05	0.00101	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.89e-05	0.00101	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	1.89e-05	0.00101	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—C3—systemic lupus erythematosus	1.88e-05	0.001	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.88e-05	0.001	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.87e-05	0.000999	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PTGS2—systemic lupus erythematosus	1.84e-05	0.000986	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TLR9—systemic lupus erythematosus	1.84e-05	0.000983	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.82e-05	0.000976	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—F2—systemic lupus erythematosus	1.82e-05	0.000971	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—F2—systemic lupus erythematosus	1.82e-05	0.000971	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.8e-05	0.000962	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—JUNB—systemic lupus erythematosus	1.79e-05	0.000958	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.78e-05	0.000952	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.78e-05	0.000951	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.77e-05	0.000949	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—C3—systemic lupus erythematosus	1.76e-05	0.000941	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.75e-05	0.000937	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—C3—systemic lupus erythematosus	1.74e-05	0.000929	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—IL6—systemic lupus erythematosus	1.72e-05	0.00092	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.7e-05	0.00091	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—F2—systemic lupus erythematosus	1.7e-05	0.000909	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	1.69e-05	0.000902	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.68e-05	0.000899	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—F2—systemic lupus erythematosus	1.68e-05	0.000898	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.66e-05	0.000886	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PRL—systemic lupus erythematosus	1.65e-05	0.000882	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—F2—systemic lupus erythematosus	1.65e-05	0.000882	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CSK—systemic lupus erythematosus	1.64e-05	0.000876	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—JUNB—systemic lupus erythematosus	1.63e-05	0.00087	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.62e-05	0.000866	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	1.62e-05	0.000864	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.55e-05	0.00083	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.55e-05	0.000826	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—F2—systemic lupus erythematosus	1.54e-05	0.000826	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—EP300—systemic lupus erythematosus	1.53e-05	0.00082	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.53e-05	0.00082	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	1.53e-05	0.000818	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—F2—systemic lupus erythematosus	1.53e-05	0.000816	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—JUNB—systemic lupus erythematosus	1.52e-05	0.000814	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	1.51e-05	0.000806	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—JUNB—systemic lupus erythematosus	1.5e-05	0.000805	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NCF2—systemic lupus erythematosus	1.5e-05	0.000801	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PRL—systemic lupus erythematosus	1.5e-05	0.000801	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—C3—systemic lupus erythematosus	1.5e-05	0.0008	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LYN—systemic lupus erythematosus	1.49e-05	0.000796	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.47e-05	0.000786	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.47e-05	0.000786	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.47e-05	0.000784	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.46e-05	0.000781	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.45e-05	0.000774	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.43e-05	0.000764	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PRL—systemic lupus erythematosus	1.4e-05	0.00075	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.39e-05	0.000743	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PRL—systemic lupus erythematosus	1.39e-05	0.000741	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.38e-05	0.000736	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.37e-05	0.000732	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.36e-05	0.000727	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—C3—systemic lupus erythematosus	1.36e-05	0.000726	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.35e-05	0.00072	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.33e-05	0.000714	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—JAK1—systemic lupus erythematosus	1.32e-05	0.000706	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—F2—systemic lupus erythematosus	1.31e-05	0.000702	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6—systemic lupus erythematosus	1.3e-05	0.000694	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCR5—systemic lupus erythematosus	1.25e-05	0.000669	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.25e-05	0.000668	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.24e-05	0.00066	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.23e-05	0.000659	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL2—systemic lupus erythematosus	1.22e-05	0.000654	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.22e-05	0.000654	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—C3—systemic lupus erythematosus	1.22e-05	0.000653	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—JAK1—systemic lupus erythematosus	1.2e-05	0.000641	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.2e-05	0.00064	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—F2—systemic lupus erythematosus	1.19e-05	0.000638	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JUNB—systemic lupus erythematosus	1.18e-05	0.000629	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.15e-05	0.000612	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCR5—systemic lupus erythematosus	1.14e-05	0.000607	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.13e-05	0.000605	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.12e-05	0.0006	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.12e-05	0.000598	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.12e-05	0.000597	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2—systemic lupus erythematosus	1.11e-05	0.000594	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—C3—systemic lupus erythematosus	1.11e-05	0.000593	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—JAK1—systemic lupus erythematosus	1.11e-05	0.000593	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PRL—systemic lupus erythematosus	1.08e-05	0.000579	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—F2—systemic lupus erythematosus	1.07e-05	0.000574	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.06e-05	0.000569	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.06e-05	0.000568	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCR5—systemic lupus erythematosus	1.05e-05	0.000562	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.05e-05	0.00056	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.04e-05	0.000556	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—C3—systemic lupus erythematosus	1.04e-05	0.000556	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.04e-05	0.000554	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CD80—systemic lupus erythematosus	1.03e-05	0.00055	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2—systemic lupus erythematosus	1.03e-05	0.000549	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—C3—systemic lupus erythematosus	1.03e-05	0.000549	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—F2—systemic lupus erythematosus	9.74e-06	0.000521	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	9.65e-06	0.000516	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL2—systemic lupus erythematosus	9.56e-06	0.000511	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CD80—systemic lupus erythematosus	9.34e-06	0.000499	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—F2—systemic lupus erythematosus	9.12e-06	0.000488	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—F2—systemic lupus erythematosus	9.02e-06	0.000482	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	8.84e-06	0.000473	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CD80—systemic lupus erythematosus	8.75e-06	0.000468	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TYK2—systemic lupus erythematosus	8.68e-06	0.000464	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL2—systemic lupus erythematosus	8.68e-06	0.000464	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JAK1—systemic lupus erythematosus	8.66e-06	0.000463	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CD80—systemic lupus erythematosus	8.64e-06	0.000462	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOS3—systemic lupus erythematosus	8.52e-06	0.000456	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCR5—systemic lupus erythematosus	8.21e-06	0.000439	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL2—systemic lupus erythematosus	8.13e-06	0.000435	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	8.09e-06	0.000433	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL2—systemic lupus erythematosus	8.04e-06	0.00043	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2—systemic lupus erythematosus	8.03e-06	0.000429	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—C3—systemic lupus erythematosus	8.02e-06	0.000429	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TYK2—systemic lupus erythematosus	7.89e-06	0.000422	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOS3—systemic lupus erythematosus	7.74e-06	0.000414	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.68e-06	0.000411	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TYK2—systemic lupus erythematosus	7.38e-06	0.000395	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.38e-06	0.000395	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TYK2—systemic lupus erythematosus	7.3e-06	0.00039	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOS3—systemic lupus erythematosus	7.25e-06	0.000388	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2—systemic lupus erythematosus	7.23e-06	0.000386	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—systemic lupus erythematosus	7.19e-06	0.000384	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOS3—systemic lupus erythematosus	7.16e-06	0.000383	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—F2—systemic lupus erythematosus	7.04e-06	0.000377	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MMP9—systemic lupus erythematosus	6.84e-06	0.000366	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.81e-06	0.000364	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CD80—systemic lupus erythematosus	6.75e-06	0.000361	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.7e-06	0.000358	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2—systemic lupus erythematosus	6.56e-06	0.000351	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—systemic lupus erythematosus	6.53e-06	0.000349	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EP300—systemic lupus erythematosus	6.48e-06	0.000347	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	6.28e-06	0.000336	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.28e-06	0.000336	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MMP9—systemic lupus erythematosus	6.21e-06	0.000332	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.2e-06	0.000332	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.19e-06	0.000331	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2—systemic lupus erythematosus	6.14e-06	0.000328	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.14e-06	0.000328	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—systemic lupus erythematosus	6.11e-06	0.000327	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	6.1e-06	0.000326	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2—systemic lupus erythematosus	6.07e-06	0.000325	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—systemic lupus erythematosus	6.04e-06	0.000323	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EP300—systemic lupus erythematosus	5.89e-06	0.000315	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MMP9—systemic lupus erythematosus	5.82e-06	0.000311	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.79e-06	0.00031	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MMP9—systemic lupus erythematosus	5.75e-06	0.000307	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.73e-06	0.000306	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	5.7e-06	0.000305	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.64e-06	0.000301	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	5.6e-06	0.000299	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.58e-06	0.000298	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EP300—systemic lupus erythematosus	5.51e-06	0.000295	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EP300—systemic lupus erythematosus	5.45e-06	0.000291	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.22e-06	0.000279	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.16e-06	0.000276	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.12e-06	0.000274	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.85e-06	0.000259	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.85e-06	0.000259	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.79e-06	0.000256	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2—systemic lupus erythematosus	4.74e-06	0.000254	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.74e-06	0.000253	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	4.72e-06	0.000252	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	4.49e-06	0.00024	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.47e-06	0.000239	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.36e-06	0.000233	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EP300—systemic lupus erythematosus	4.26e-06	0.000228	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—systemic lupus erythematosus	4.25e-06	0.000227	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.03e-06	0.000216	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—systemic lupus erythematosus	3.86e-06	0.000206	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.81e-06	0.000204	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.7e-06	0.000198	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—systemic lupus erythematosus	3.61e-06	0.000193	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—systemic lupus erythematosus	3.57e-06	0.000191	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	3.42e-06	0.000183	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.17e-06	0.00017	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—systemic lupus erythematosus	2.79e-06	0.000149	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	2.16e-06	0.000115	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	1.94e-06	0.000104	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	1.86e-06	9.93e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.7e-06	9.08e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.41e-06	7.55e-05	CbGpPWpGaD
